Juan Carlos Núñez-Enríquez
Mexican Social Security Institute
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Juan Carlos Núñez-Enríquez.
BioMed Research International | 2014
Vilma Carolina Bekker-Méndez; Enrique Miranda-Peralta; Juan Carlos Núñez-Enríquez; Irma Olarte-Carrillo; Francisco Xavier Guerra-Castillo; Ericka N. Pompa-Mera; Alicia Ocaña-Mondragón; Angélica Rangel-López; Roberto Bernáldez-Ríos; Aurora Medina-Sanson; Elva Jiménez-Hernández; Raquel Amador-Sánchez; José Gabriel Peñaloza-González; José de Diego Flores-Chapa; Arturo Fajardo-Gutiérrez; Janet Flores-Lujano; María del Carmen Rodríguez-Zepeda; Elisa Dorantes-Acosta; Victoria Bolea-Murga; Nancy Núñez-Villegas; Martha Margarita Velázquez-Aviña; José Refugio Torres-Nava; Nancy Reyes-Zepeda; César González-Bonilla; Juan Manuel Mejía-Aranguré
Mexico has one of the highest incidences of childhood leukemia worldwide and significantly higher mortality rates for this disease compared with other countries. One possible cause is the high prevalence of gene rearrangements associated with the etiology or with a poor prognosis of childhood acute lymphoblastic leukemia (ALL). The aims of this multicenter study were to determine the prevalence of the four most common gene rearrangements [ETV6-RUNX1, TCF3-PBX1, BCR-ABL1, and MLL rearrangements] and to explore their relationship with mortality rates during the first year of treatment in ALL children from Mexico City. Patients were recruited from eight public hospitals during 2010–2012. A total of 282 bone marrow samples were obtained at each childs diagnosis for screening by conventional and multiplex reverse transcription polymerase chain reaction to determine the gene rearrangements. Gene rearrangements were detected in 50 (17.7%) patients. ETV6-RUNX1 was detected in 21 (7.4%) patients, TCF3-PBX1 in 20 (7.1%) patients, BCR-ABL1 in 5 (1.8%) patients, and MLL rearrangements in 4 (1.4%) patients. The earliest deaths occurred at months 1, 2, and 3 after diagnosis in patients with MLL, ETV6-RUNX1, and BCR-ABL1 gene rearrangements, respectively. Gene rearrangements could be related to the aggressiveness of leukemia observed in Mexican children.
British Journal of Cancer | 2013
Juan Carlos Núñez-Enríquez; Arturo Fajardo-Gutiérrez; E P Buchán-Durán; Roberto Bernáldez-Ríos; Aurora Medina-Sanson; Elva Jiménez-Hernández; Raquel Amador-Sánchez; José Gabriel Peñaloza-González; Rogelio Paredes-Aguilera; Francisco Javier Álvarez-Rodríguez; Victoria Bolea-Murga; J. de Diego Flores-Chapa; Janet Flores-Lujano; Vilma Carolina Bekker-Méndez; Roberto Rivera-Luna; M del Carmen Rodriguez-Zepeda; Angélica Rangel-López; Elisa Dorantes-Acosta; Nora Nancy Núñez-Villegas; Martha Margarita Velázquez-Aviña; José Refugio Torres-Nava; Nancy Reyes-Zepeda; Rocio Cardenas-Cardos; Luz Victoria Flores-Villegas; Armando Martínez-Avalos; Fabio Salamanca-Gómez; C Gorodezky; José Arellano-Galindo; Juan Manuel Mejía-Aranguré
Background:Allergies have been described as protective factors against the development of childhood acute leukaemia (AL). Our objective was to investigate the associations between allergy history and the development of AL and acute lymphoblastic leukaemia (ALL) in children with Down syndrome (DS).Methods:A case–control study was performed in Mexico City. The cases (n=97) were diagnosed at nine public hospitals, and the controls (n=222) were recruited at institutions for children with DS. Odds ratios (OR) were calculated.Results:Asthma was positively associated with AL development (OR=4.18; 95% confidence interval (CI): 1.47–11.87), whereas skin allergies were negatively associated (OR=0.42; 95% CI: 0.20–0.91).Conclusion:Our findings suggest that allergies and AL in children with DS share biological and immune mechanisms. To our knowledge, this is the first study reporting associations between allergies and AL in children with DS.
Leukemia & Lymphoma | 2017
Jorge Alfonso Martín-Trejo; Juan Carlos Núñez-Enríquez; Arturo Fajardo-Gutiérrez; Aurora Medina-Sanson; Janet Flores-Lujano; Elva Jiménez-Hernández; Raquel Amador-Sánchez; José Gabriel Peñaloza-González; Francisco Javier Álvarez-Rodríguez; Victoria Bolea-Murga; Rosa Martha Espinosa-Elizondo; José de Diego Flores-Chapa; María Luisa Pérez-Saldivar; María del Carmen Rodríguez-Zepeda; Elisa Dorantes-Acosta; Nora Nancy Núñez-Villegas; Martha Margarita Velázquez-Aviña; José Refugio Torres-Nava; Nancy Reyes-Zepeda; César González-Bonilla; Luz Victoria Flores-Villegas; Angélica Rangel-López; Roberto Rivera-Luna; Rogelio Paredes-Aguilera; Rocio Cardenas-Cardos; Armando Martínez-Avalos; Ana Elena Gil-Hernández; David Aldebarán Duarte-Rodríguez; Juan Manuel Mejía-Aranguré
Abstract The role of malnutrition at diagnosis as a predictor of early mortality in Mexican leukemia children remains controversial. The objective of present study was to investigate whether malnutrition was a predictor of early mortality during the first year of treatment in Mexican acute lymphoblastic leukemia (ALL) children through the first population-based study. A total of 794 newly diagnosed ALL pediatric patients from public hospitals of Mexico City were enrolled. A multivariate Cox proportional hazards regression model was constructed and adjusted by patient’s age at diagnosis, gender, hospital of treatment, and socioeconomic status. Early mortality was high (12.1%) and malnutrition by different indicators was not associated with mortality at induction phase and at 6th month; a high risk of dying (RR = 2.08; 95% CI: 1.08–4.01) was observed in the group of malnourished children with a high-risk ALL.
BioMed Research International | 2014
Abigail Morales-Sánchez; Ericka N. Pompa-Mera; Arturo Fajardo-Gutiérrez; Francisco Javier Álvarez-Rodríguez; Vilma Carolina Bekker-Méndez; J. de Diego Flores-Chapa; Janet Flores-Lujano; Elva Jiménez-Hernández; José Gabriel Peñaloza-González; María del Carmen Rodríguez-Zepeda; José Refugio Torres-Nava; Martha Margarita Velázquez-Aviña; Raquel Amador-Sánchez; Martha Alvarado-Ibarra; Nancy Reyes-Zepeda; Rosa Martha Espinosa-Elizondo; María Luisa Pérez-Saldivar; Juan Carlos Núñez-Enríquez; Juan Manuel Mejía-Aranguré; Ezequiel M. Fuentes-Pananá
Acute lymphoblastic leukemia (ALL) is the most common cancer in childhood worldwide and Mexico has reported one of the highest incidence rates. An infectious etiology has been suggested and supported by epidemiological evidences; however, the identity of the involved agent(s) is not known. We considered that early transmitted lymphotropic herpes viruses were good candidates, since transforming mechanisms have been described for them and some are already associated with human cancers. In this study we interrogated the direct role of EBV, HCMV, HHV6, and HHV7 human herpes viruses in childhood ALL. Viral genomes were screened in 70 bone marrow samples from ALL patients through standard and a more sensitive nested PCR. Positive samples were detected only by nested PCR indicating a low level of infection. Our result argues that viral genomes were not present in all leukemic cells, and, hence, infection most likely was not part of the initial genetic lesions leading to ALL. The high statistical power of the study suggested that these agents are not involved in the genesis of ALL in Mexican children. Additional analysis showed that detected infections or coinfections were not associated with prognosis.
Archives of Medical Research | 2016
Juan Carlos Balandrán; Eduardo Vadillo; David Dozal; Alfonso Reyes-López; Antonio Sandoval-Cabrera; Merle Denisse Laffont-Ortiz; Jessica L. Prieto-Chávez; Armando Vilchis-Ordóñez; Henry Quintela-Núñez del Prado; Hector Mayani; Juan Carlos Núñez-Enríquez; Juan Manuel Mejía-Aranguré; Briceida López-Martínez; Elva Jiménez-Hernández; Rosana Pelayo
BACKGROUND AND AIMS Childhood acute leukemias (AL) are characterized by the excessive production of malignant precursor cells at the expense of effective blood cell development. The dominance of leukemic cells over normal progenitors may result in either direct suppression of functional hematopoiesis or remodeling of microenvironmental niches, contributing to BM failure and AL-associated mortality. We undertook this study to investigate the contents and functional activity of hematopoietic stem/progenitor cells (HSPC) and their relationship to immune cell production and risk status in AL pediatric patients. METHODS Multiparametric flow cytometry of BM aspirates was performed to classify AL on the basis of lineage and differentiation stages and to analyze HSPC and immune cell frequencies. Controlled co-culture systems were conducted to evaluate functional lineage potentials of primitive cells. Statistical correlations and inter-group significant differences were established. RESULTS Among 113 AL BM aspirates, 26.5% corresponded to ProB, 19.5% to PreB and 32% contain ProB and PreB differentiation stages, whereas nearly 9% of the cases were T- and 13% myeloid-lineage leukemias. We identified ProB-ALL as the subtype endowed with the highest relative contents of HSPC, whereas T-ALL and PreB-ALL showed a critically reduced size of both HSC and MLP compartments. Notably, lower cell frequencies of HSPC in ProB-ALL correlated to high-risk prognosis at disease debut. CONCLUSIONS HSPC abundance at initial diagnosis may aid to predict the clinical course of ALL and to identify high-risk patients. A clearer understanding of their population dynamics and functional properties in the leukemia setting will potentially pave the way for targeted therapies.
robotics, automation and mechatronics | 2018
Irving Jesús Vivas-Rosales; Mariana Hernández-Ojeda; Patricia María O'Farrill-Romanillos; Diana Andrea Herrera-Sánchez; Abril Helena Maciel-Fierro; Juan Carlos Núñez-Enríquez
BACKGROUND Common variable immunodeficiency (CVID) is the most common primary symptomatic humoral immunodeficiency in adults. Antibody deficiency entails higher susceptibility to sinopulmonary infections and bronchiectasis formation, which is related to increased mortality. Scales have been established to assess the degree of severity of bronchiectasis in order to predict outcomes such as mortality, exacerbations and hospitalizations. OBJECTIVE To determine bronchiectasis severity in adult patients with common variable immunodeficiency using the Brief Symptom Inventory scale. METHOD Cross-sectional study in adult population diagnosed with common variable immunodeficiency and attended to at the Mexican Institute of Social Security National Medical Center Siglo XXI Specialty Hospital. RESULTS Bronchiectasis severity according to the Brief Symptom Inventory was mild in 60% of patients and moderate in 40%. Statistically significant differences were found for body mass index, number of affected lobes and type of bronchiectasis (p < 0.001). CONCLUSIONS Using bronchiectasis severity scales in patients with common variable immunodeficiency is indispensable for clinical and therapeutic decision making; however, determining the most appropriate instrument to assess bronchiectasis severity in this population is necessary.
Cancer Medicine | 2018
Elva Jiménez-Hernández; Arturo Fajardo-Gutiérrez; Juan Carlos Núñez-Enríquez; Jorge Alfonso Martín-Trejo; Laura Eugenia Espinoza-Hernández; Janet Flores-Lujano; José Arellano-Galindo; Aurora Medina-Sansón; Rogelio Paredes-Aguilera; Laura Elizabeth Merino-Pasaye; Martha Margarita Velázquez-Aviña; José Refugio Torres-Nava; Rosa Martha Espinosa-Elizondo; Raquel Amador-Sánchez; Juan José Dosta-Herrera; Javier Anastacio Mondragón-García; Heriberto Valdés-Guzmán; Laura Mejía-Pérez; Gilberto Espinoza-Anrubio; María Minerva Paz-Bribiesca; Perla Salcedo-Lozada; Rodolfo Ángel Landa-García; Rosario Ramírez-Colorado; Luis Hernández-Mora; María Luisa Pérez-Saldivar; Marlene Santamaría-Ascencio; Anselmo López-Loyola; Arturo Hermilo Godoy-Esquivel; Luis Ramiro García-López; Alison Ireri Anguiano-Ávalos
In Mexico, due to the high rates of diabetes, overweight, and obesity, there has also been noted an increased newborn weight, which may be contributing to the elevated incidence rate of childhood acute leukemia (AL). We conducted a case–control study in public hospitals of Mexico City aimed to know whether a greater weight at birth is associated with a higher risk of developing leukemia. We included incident cases with acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) diagnosed between 2010 and 2015. Controls were frequency‐matched to the cases by age, sex, and health institution. Logistic regression analysis was performed adjusting risks by childs sex, overcrowding index, birth order, and mothers age at the time of pregnancy. Adjusted odds ratios (aORs) and 95% confidence intervals were calculated. A total of 1455 cases and 1455 controls were included. An evident association between ALL and childs birthweight ≥2500 g was found (aOR 2.06; 95% CI: 1.59, 2.66) and also, in those with birthweight ≥3500 g (aOR 1.19; 95% CI: 1.00, 1.41). In AML patients with birthweight ≥2500 g and ≥3500 g, an aOR of 1.77 (95% CI: 1.07, 2.94) and 1.42 (95% CI: 1.03–1.95) was observed, respectively. No association was noticed with either type of AL and a birthweight ≥4000 g. To sum up, we found a moderate association between not having a low birthweight and an increased risk of acute leukemias. Birthweight ≥3500 g was also a risk factor for both types of leukemia. This suggests that a greater birthweight may increase the risk of acute leukemias in Mexican children.
Revista chilena de pediatría | 2017
Elsa Nohemí Reyes-Flandes; Alejandro Herrera-Landero; Pascual Bobadilla-González; Juan Carlos Núñez-Enríquez
Acute renal failure (ARF) is a complication associated with cardiac surgery with cardiopulmonary bypass (CPB) with an impact on morbidity and mortality. OBJECTIVE To identify risk factors associated with postoperative IRA according to pediatric Risk, Injury, Failure, Loss, End-Stage Renal Disease scale in children undergoing cardiac surgery with CPB. PATIENTS AND METHOD A nested case-control study was conducted. We included children under 16 years of age attended postoperative for CBP in a pediatric intensive care unit over a period of 18 months. The cases were those who developed ARF according to the classification pediatric Risk, Injury, Failure, Loss, End-Stage Renal Disease scale during their stay in the pediatric intensive care unit. Controls were those who did not develop this complication. Logistic regression analysis was performed and adjusted odds ratio (OR) and confidence intervals at 95% (95% CI) were calculated. RESULTS 91 patients (31 cases and 60 controls) with a median age of 20 months and predominance of males (53.8%) were analyzed. Independent risk factors for ARF were the intraoperative lactate level > 6 mmol/l (OR = 4.91; 95% CI 1.26-19.05; p = .02) and cyanotic heart disease (OR = 3.62; 95% CI 1.11-11.63; p = .03). CONCLUSIONS This study identified that pediatric patients with lactate levels >6 mmol/l during CPB and those with cyanotic congenital heart disease are a subgroup of high risk to develop ARF after heart surgery and should be closely monitored to prevent, detect and/or treat this complication timely manner.
Archive | 2016
Juan Carlos Núñez-Enríquez; Janet Flores-Lujano; Vilma Carolina Bekker-Méndez; David Aldebarán Duarte-Rodríguez; Juan Manuel Mejía-Aranguré
Acute leukemia (AL) is the most common type of cancer in children under 15 years of age and represents one of the leading causes of mortality among children worldwide. Despite advancements in the knowledge of the biology and treatment of AL, the etiology remains unresolved. A small number of risk factors have been reported as established for the development of this disease, but they explain less than 10 % of cases, leaving 90 % of cases without an identified causation.
Archives of Medical Research | 2016
Beatriz Rosales-Rodríguez; Fernando Fernández-Ramírez; Juan Carlos Núñez-Enríquez; Ana Claudia Velázquez-Wong; Aurora Medina-Sanson; Elva Jiménez-Hernández; Janet Flores-Lujano; José Gabriel Peñaloza-González; Rosa Martha Espinosa-Elizondo; María Luisa Pérez-Saldivar; José Refugio Torres-Nava; Jorge Alfonso Martín-Trejo; Gabriela Bibiana Martínez-Morales; Vilma Carolina Bekker-Méndez; Juan Manuel Mejía-Aranguré; Haydeé Rosas-Vargas
B-cell precursor acute lymphocytic leukemia (B-ALL) represents a worldwide public health issue. Particularly, Mexico is one of the countries with the highest incidence of ALL in children. Between the multiple factors involved in ALL etiology, genetic alterations are clearly one of the most relevant features. In this work, a group of 24 B-ALL patients, all negative for the four most frequent gene fusions (ETV6-RUNX1, BCR-ABL1, TCF3-PBX1 and MLL-AF4), were included in a high-resolution microarray analysis in order to evaluate genomic copy-number alterations (CNAs). The results of this preliminary report showed a broad genomic heterogeneity among the studied samples; 58% of the patients were hyperdiploid and 33% displayed a chromosome 9p deletion of variable length affecting genes CDKN2A/B, two patients displayed genomic instability with a high number of focal CNAs, three patients presented unique duplications affecting 2q, 12p and 1q, respectively, and one patient displayed no copy number imbalances. The copy-number profile of 44 genes previously related to B-ALL was heterogeneous as well. Overall results highlight the need for a detailed description of the genetic alterations in ALL cancer cells in order to understand the molecular pathogenesis of the disease and to identify any prognostic markers with clinical significance.